LK

Lalit Kumar Sharma

Active Director Director DIN 11609484
DIN 11609484 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Lalit Kumar Sharma

Data last updated:

Lalit Kumar Sharma is a Director at Avyu Pharmaceutical Private Limited (since 2026).

DIN 11609484
Primary Designation Director
First Appointment 16 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avyu Pharmaceutical Private Limited U46497HP2026PTC012528
Director16 Mar 20262026Active

Board colleagues of Lalit Kumar Sharma

NameDINCompanyDesignation
Gaurav Tanwar11609483Avyu Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avyu Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Lalit Kumar Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalit Kumar Sharma

Lalit Kumar Sharma currently holds 1 directorship: Avyu Pharmaceutical Private Limited (Director, since 16 Mar 2026).

Lalit Kumar Sharma was first appointed on 16 Mar 2026 as Director at Avyu Pharmaceutical Private Limited.

The current boards of Lalit Kumar Sharma's companies include Gaurav Tanwar (Avyu Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available